🧠 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Hangzhou Tigermed Consulting (300347)

Shenzhen
Currency in CNY
Disclaimer
48.99
+0.15(+0.31%)
Closed
300347 Scorecard
Full Analysis
Has raised its dividend for 4 consecutive years
Fair Value
Day's Range
48.3549.37
52 wk Range
36.1273.19
Bid/Ask
48.99 / 49.01
Prev. Close
48.84
Open
48.9
Day's Range
48.35-49.37
52 wk Range
36.12-73.19
Volume
3,278,142
Average Volume (3m)
7,915,748
1-Year Change
-22.53%
Fair Value
Unlock
Fair Value Upside
Unlock
300347 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
69.52
Upside
+41.91%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Life Sciences Tools & Services industry
Show more

Hangzhou Tigermed Consulting Company Profile

Hangzhou Tigermed Consulting Co., Ltd provides contract research organization services in the People’s Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, clinical development strategy, site management, subject recruitment, medical device/ in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. It also provides product market research, product marketing strategy, product finalization, product verification, registration strategy planning, marketing application, post-marketing supports, and product upgrade services. In addition, the company offers medical imaging, pharmacovigilance, medical translation, quality assurance, GMP consulting, central laboratories, functional services, EDC system, and call center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People’s Republic of China.

Compare 300347 to Peers and Sector

Metrics to compare
300347
Peers
Sector
Relationship
P/E Ratio
34.6x21.2x−0.6x
PEG Ratio
−0.71−0.380.00
Price/Book
1.9x1.9x2.6x
Price / LTM Sales
5.6x2.9x3.1x
Upside (Analyst Target)
29.4%32.7%55.7%
Fair Value Upside
Unlock32.6%6.8%Unlock

FAQ

What Is the Hangzhou Tigermed Consulting (300347) Stock Price Today?

The Hangzhou Tigermed Consulting stock price today is 48.99

What Stock Exchange Does Hangzhou Tigermed Consulting Trade On?

Hangzhou Tigermed Consulting is listed and trades on the Shenzhen stock exchange.

What Is the Stock Symbol for Hangzhou Tigermed Consulting?

The stock symbol for Hangzhou Tigermed Consulting is "300347."

Does Hangzhou Tigermed Consulting Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 1.16%.

What Is the Hangzhou Tigermed Consulting Market Cap?

As of today, Hangzhou Tigermed Consulting market cap is 39.12B.

What is Hangzhou Tigermed Consulting Earnings Per Share?

The Hangzhou Tigermed Consulting EPS is 1.30.

What Is the Next Hangzhou Tigermed Consulting Earnings Date?

Hangzhou Tigermed Consulting will release its next earnings report on Oct 30, 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.